comparemela.com

மையங்கள் நோய் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

California man who received Johnson & Johnson COVID-19 vaccine hospitalized with blood clot

NYU Langone associate professor Dr. Roshini Raj on the Centers for Disease Control and Prevention lifting the Johnson & Johnson vaccine pause A male patient is under care at the University of California San Francisco medical center for blood clotting after he received the Johnson & Johnson COVID-19vaccine, a spokeswoman confirmed to Fox News. To the best of our knowledge, this is the first male patient with VITT (vaccine-induced thrombotic thrombocytopenia) syndrome in the U.S. following the U.S. emergency authorization of the Johnson & Johnson vaccine on Feb. 27, 2021, UCSF spokeswoman Suzanne Leigh said in a statement. The Bay Area patient is in his early 30s, is making a good recovery and is expected to be discharged within a few days, Leigh said.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.